LFCR lifecore.com: מקדם חוב לטווח ארוך להון

This daily price chart for Lifecore Biomedical (LFCR) illustrates the asset's dynamics, with a value of 8.98. Lifecore Biomedical (LFCR) serves as a CDMO partner for biotech startups, maintaining a leadership position in hyaluronic acid purification. The company is currently scaling the production of sterile injectables while renegotiating B2B contracts. Stable demand in orthopedics and ophthalmology renders these services independent of economic crises, ensuring resilience.

This indicator reflects the ratio of liabilities with a maturity of over one year to equity, determining the degree of financial leverage and the stability of the business's solvency. By analyzing the change in long-term debt to equity, an investor can assess how effectively the recovery of sterile injectables contract manufacturing at Lifecore Biomedical (LFCR) offsets the debt burden incurred during the period of restructuring and reporting delays.